These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 12958466)
1. Clinical trials. Farrington P; Miller E Methods Mol Med; 2003; 87():335-52. PubMed ID: 12958466 [No Abstract] [Full Text] [Related]
2. A 25-year review of sequential methodology in clinical studies. Todd S Stat Med; 2007 Jan; 26(2):237-52. PubMed ID: 17139691 [TBL] [Abstract][Full Text] [Related]
4. Re: Design and endpoints of clinical trials in hepatocellular carcinoma. Di Maio M; Daniele B; Gallo C; Perrone F J Natl Cancer Inst; 2008 Nov; 100(21):1557; author reply 1557-8. PubMed ID: 18957679 [No Abstract] [Full Text] [Related]
5. An overview of clinical trials. Rich K J Vasc Nurs; 2004 Mar; 22(1):32-4. PubMed ID: 14981501 [No Abstract] [Full Text] [Related]
6. A strategic framework for novel drug development in multiple myeloma. Anderson KC; Hannah AL; Pazdur R; Farrell AT Br J Haematol; 2007 Jul; 138(2):153-9. PubMed ID: 17593022 [No Abstract] [Full Text] [Related]
7. Design and endpoints of clinical trials in hepatocellular carcinoma. Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ; J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic vaccine trails in Thailand. Churdboonchart V J HIV Ther; 2004 Sep; 9(3):57-9. PubMed ID: 15534562 [TBL] [Abstract][Full Text] [Related]
9. Field assays with anti-malarial vaccines: phase III protocols. Sanchez T Rev Inst Med Trop Sao Paulo; 1992 Apr; 34 Suppl 9():S24-7. PubMed ID: 1340629 [No Abstract] [Full Text] [Related]
10. Epidemiological factors in clinical trial design. Wassilak S Dev Biol Stand; 1998; 95():75-83. PubMed ID: 9855417 [TBL] [Abstract][Full Text] [Related]
11. Designing phase III or IV trials for vaccines: choosing between individual or cluster randomised trial designs. Vaucher P Vaccine; 2009 Mar; 27(13):1928-31. PubMed ID: 19368773 [TBL] [Abstract][Full Text] [Related]
12. Clinical trials referral resource. Current phase II and phase III clinical trials in the treatment of colorectal cancer. Mooney MM; Schoenfeldt M Oncology (Williston Park); 2004 Oct; 18(11):1396, 1401, 1404 passim. PubMed ID: 15609469 [No Abstract] [Full Text] [Related]
13. New paradigm in dose-finding trials: patient-specific dosing and beyond phase I. Rogatko A; Babb JS; Tighiouart M; Khuri FR; Hudes G Clin Cancer Res; 2005 Aug; 11(15):5342-6. PubMed ID: 16061846 [TBL] [Abstract][Full Text] [Related]
14. Clinical trials part II. Burgess G Surviv News (Atlanta Ga); 2002 Jul; ():12. PubMed ID: 12238473 [No Abstract] [Full Text] [Related]
15. Clinical trials referral resource. Current clinical trials in rhabdomyosarcoma. Anderson BD; Schoenfeldt M Oncology (Williston Park); 2005 Sep; 19(10):1319-20, 1330. PubMed ID: 16285226 [No Abstract] [Full Text] [Related]
16. Monitoring and safety assessment in Phase I to III clinical trials. Fescharek R; Nicolay U; Arras-Reiter C Dev Biol Stand; 1998; 95():203-9. PubMed ID: 9855433 [TBL] [Abstract][Full Text] [Related]
17. Sample size tables for exact single-stage phase II designs. A'Hern RP Stat Med; 2001 Mar; 20(6):859-66. PubMed ID: 11252008 [TBL] [Abstract][Full Text] [Related]